152 related articles for article (PubMed ID: 19948877)
1. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.
Carrero JJ; Witasp A; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Suliman ME; Anderstam B; Lindholm B; Nordfors L; Schalling M; Axelsson J
Nephrol Dial Transplant; 2010 Mar; 25(3):901-6. PubMed ID: 19948877
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
3. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
[TBL] [Abstract][Full Text] [Related]
4. Anorexia and plasma levels of free tryptophan, branched chain amino acids, and ghrelin in hemodialysis patients.
Bossola M; Scribano D; Colacicco L; Tavazzi B; Giungi S; Zuppi C; Luciani G; Tazza L
J Ren Nutr; 2009 May; 19(3):248-55. PubMed ID: 19243975
[TBL] [Abstract][Full Text] [Related]
5. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
7. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids.
Siahanidou T; Margeli A; Kappis A; Papassotiriou I; Mandyla H
Metabolism; 2011 Mar; 60(3):389-93. PubMed ID: 20359723
[TBL] [Abstract][Full Text] [Related]
8. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
[TBL] [Abstract][Full Text] [Related]
9. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
Oki K; Yamane K; Kamei N; Nojima H; Kohno N
Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
[TBL] [Abstract][Full Text] [Related]
10. Appetite-regulating hormones in chronic kidney disease patients.
Oner-Iyidogan Y; Gurdol F; Kocak H; Oner P; Cetinalp-Demircan P; Caliskan Y; Kocak T; Turkmen A
J Ren Nutr; 2011 Jul; 21(4):316-21. PubMed ID: 21193324
[TBL] [Abstract][Full Text] [Related]
11. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
12. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
[TBL] [Abstract][Full Text] [Related]
13. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
16. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol.
Jin H; Jiang B; Tang J; Lu W; Wang W; Zhou L; Shang W; Li F; Ma Q; Yang Y; Chen M
Diabetes Res Clin Pract; 2008 Mar; 79(3):412-8. PubMed ID: 18241953
[TBL] [Abstract][Full Text] [Related]
17. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.
Chen CC; Li TC; Li CI; Liu CS; Lin WY; Wu MT; Lai MM; Lin CC
Metabolism; 2007 Sep; 56(9):1216-20. PubMed ID: 17697864
[TBL] [Abstract][Full Text] [Related]
18. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
19. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
[TBL] [Abstract][Full Text] [Related]
20. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]